First National Bank Sioux Falls’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-629
Closed -$45K 162
2016
Q3
$45K Hold
629
0.12% 125
2016
Q2
$47K Hold
629
0.15% 102
2016
Q1
$41K Buy
629
+150
+31% +$10.2K 0.14% 108
2015
Q4
$37K Hold
479
0.12% 119
2015
Q3
$39K Hold
479
0.13% 114
2015
Q2
$42K Hold
479
0.12% 118
2015
Q1
$42K Hold
479
0.12% 117
2014
Q4
$40K Hold
479
0.11% 116
2014
Q3
$40K Hold
479
0.11% 116
2014
Q2
$39K Hold
479
0.1% 122
2014
Q1
$36K Hold
479
0.1% 122
2013
Q4
$35K Hold
479
0.09% 128
2013
Q3
$33K Hold
479
0.1% 125
2013
Q2
$30K Buy
+479
New +$31.2K 0.09% 129

Other funds holding NVS

First National Bank Sioux Falls's NVS Position: Q4 2016 in Review

First National Bank Sioux Falls sold out of Novartis (NVS) in Q4 2016, closing a stake of 629 shares — an estimated $45K sold.

First National Bank Sioux Falls first reported a position in NVS in Q2 2013 and held it in 14 quarters. The position peaked at $47K in Q2 2016. 905 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

  • First National Bank Sioux Falls reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
  • First National Bank Sioux Falls sold 629 Novartis shares in Q4 2016, an estimated $45K.
  • First National Bank Sioux Falls first reported a position in Novartis in Q2 2013 and held it in 14 quarters.
  • First National Bank Sioux Falls's Novartis position peaked at $47K in Q2 2016.
  • 905 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on First National Bank Sioux Falls's 13F filing for Q4 2016, filed 13 Feb 2017.